Home/Filings/4/0001610717-25-000174
4//SEC Filing

Jones William Benton 4

Accession 0001610717-25-000174

CIK 0001626971other

Filed

Jun 5, 8:00 PM ET

Accepted

Jun 6, 4:26 PM ET

Size

6.6 KB

Accession

0001610717-25-000174

Insider Transaction Report

Form 4
Period: 2025-06-04
Transactions
  • Exercise/Conversion

    Warrant (Right to Buy)

    2025-06-0419,3570 total
    Exercise: $3.50From: 2024-05-06Exp: 2025-06-30Common Stock (19,357 underlying)
  • Exercise/Conversion

    Common Stock

    2025-06-04$3.50/sh+19,357$67,750173,130 total
Footnotes (1)
  • [F1]Issued at no additional consideration to the Reporting Person in connection with their subscription for shares of the Issuer's Common Stock at a price of $1.7312 per share.

Documents

1 file

Issuer

Corvus Pharmaceuticals, Inc.

CIK 0001626971

Entity typeother

Related Parties

1
  • filerCIK 0001664506

Filing Metadata

Form type
4
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:26 PM ET
Size
6.6 KB